Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 6:17 PM ET | Feedback | Site Changes | Help
A biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease.
View Ticker Page (ALKS)
Results 11 - 20 of 29 : 123
Recs
LookMomBoogers (95.01) Submitted: 8/08/08 3:11 PM : Start Price: $12.45 ALKS Score: 17.98
They are in all the right drug markets, P/E ratio is less then 10, PEG is around .2, they are guiding up, whats not to love. This company either gets bought or doubles on its own.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
lulamae12 (< 20) Submitted: 6/08/08 8:27 PM : Start Price: $12.64 ALKS Score: 16.25
ALKS, a name you will be hearing due to the development of several new drugs. ALKS is currently working with its partner, Johnson and Johnson, in the development of a drug to to treat rapidly recurring Bi-Polar disorder. Alks has also developed a...
gea1968 (52.04) Submitted: 8/15/08 8:16 PM : Start Price: $16.50 ALKS Score: -6.06
fundamentals and momentum ; favorable StockScouter rating
hihiterry (25.11) Submitted: 8/27/08 11:27 AM : Start Price: $13.49 ALKS Score: 6.40
Has been battered by Byetta when it isn't even a part of that drug's future since Lilly ended its once-a-month developement program. This was a drug delivery company which is turning itself into a pharmaceutical company.
indyjoneses (99.79) Submitted: 8/28/08 12:11 PM : Start Price: $13.27 ALKS Score: 8.79
Irrational market beating for potential molecule, which may or may not have a non-existent problem. Should do well ihf/when Long Acting Byetta gets to the market
dbillett1 (< 20) Submitted: 9/03/08 12:41 AM : Start Price: $13.71 ALKS Score: 5.26
Undervalued.
Parobek (28.46) Submitted: 2/08/08 8:41 PM : Start Price: $13.60 ALKS Score: 8.58
Week #2 - Tuesday: 'Stock Pick of the Day'
Jorgedig (21.76) Submitted: 12/28/07 10:27 AM : Start Price: $15.87 ALKS Score: 4.49
Nice biotech.
synergyltd (35.72) Submitted: 10/18/06 7:15 PM : Start Price: $16.47 ALKS Score: -2.99
stock cycles yearly between 12 and 20 and should get back to the 17-18 range in the next 6 months
hockboy41 (46.26) Submitted: 1/15/07 1:20 AM : Start Price: $13.89 ALKS Score: 11.14
Alkermes has a history of strong products from its pipeline and although it has levelled out at around $15, their drugs Vivitrol, Risperdal Consta, and AIR insulin inhalation will soon break out onto the pharmaceutical scene and their pipeline along ...
Terms & Conditions
RSS Headlines
Fool UK